MICHALLA M ROOD

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant LEWISTON, NY NPI 1144914367

General Payments — all program years on this page

$1,123.14

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 47
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $463.62 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $373.6220
Education $90.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $659.5226
2024 $463.6221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078115894 Janssen Pharmaceuticals, Inc $18.64 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086309045 Bayer Healthcare Pharmaceuticals Inc. $18.64 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086360508 Bayer Healthcare Pharmaceuticals Inc. $19.96 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101294517 E.R. Squibb & Sons, L.L.C. $17.97 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104425233 AstraZeneca Pharmaceuticals LP $14.95 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105370535 AstraZeneca Pharmaceuticals LP $16.75 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105552822 AstraZeneca Pharmaceuticals LP $15.66 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108111246 ABBVIE INC. $20.83 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108111248 ABBVIE INC. $16.62 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108111250 ABBVIE INC. $21.11 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114523002 Exact Sciences Corporation $18.31 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115889751 GlaxoSmithKline, LLC. $20.09 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116367745 GlaxoSmithKline, LLC. $20.19 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116678579 GlaxoSmithKline, LLC. $21.05 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131713371 PFIZER INC. $15.51 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135793640 Lilly USA, LLC $24.00 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135828773 Lilly USA, LLC $14.85 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137816622 Takeda Pharmaceuticals U.S.A., Inc. $24.74 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139505461 Astellas Pharma US Inc $90.00 03/19/2024 Education Undisputed 01/23/2026 View at CMS
1141956315 Merck Sharp & Dohme LLC $16.03 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141967891 Merck Sharp & Dohme LLC $17.72 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.